Last Day to Register for the Johnson & Johnson Innovation Digital Health Masterclass

Over 100 of Europe's best digital health companies have already asked to take part in the Johnson & Johnson Digital Health Masterclass and an impressive line up of some of Europe's foremost experts in healthcare, technology, business strategy and venture capital is in place to help companies deliver on their growth agenda.

Executives from the selected digital health companies will have the opportunity to enjoy the benefits of a growth-focused curriculum, expert advice, and close interaction with venture and angel financing partners. Launched in July, in partnership with Health 2.0, the Masterclass offers an opportunity for executives to take their businesses to the next level and to raise their profile with key influencers in the field of digital health.

The programme modules will include:

Session 1, Berlin - September 18th to 20th 2013

  • Clear evidence-based case for healthcare transformation and digital health
  • Detailed look at G5 Healthcare markets & innovation programmes
  • Examination of regulatory issues and compliance for digital health companies
  • Strategy Exercise- identifying core capabilities required to maintain strategic advantage

Session 2, Barcelona - October 9th to 11th 2013

  • Business model development, excercise, and expert review
  • Developing detailed growth-focused business models and related operational plans
  • Deep dive on technology and trends in each of the primary Digital Health technology verticals
  • Introduction on scaling business operations

Session 3, London - October 28th to 30th 2013

  • Scaling product and service delivery
  • Developing trials and data sets to support "evidence based" sales
  • Building executive teams, boards, and advisors that can help you scale
  • Power of Story- build a powerful company story that connects with investors and customers
  • Financing your company's growth

The programme will culminate in an Investor Day on November 20th in London, run in partnership with local venture capitalists, healthcare providers and technology companies, the day will also provide significant networking opportunities. All companies will be able to meet and to forge their own relationships directly with prospective investors and customers.

9th of August is the closing date for applications - successful applicants will not only have the opportunity to share a prize pool of €50k, they will also have a rare chance to interact with leading voices from business, healthcare, and technology.

Format: Companies selected for the Masterclass will attend a series of three 3-day workshops run in partnership with local healthcare and technology companies. Networking sessions will be held in the evening at each location

Dates: September 18th to November 20th

Workshops: European locations, finishing in London.

Challenge and Investor Day, London - 20th November 2013 in association with Health 2.0 Europe

For further information, please visit:
http://masterclass.jnjinnovation.com

Related news articles:

Most Popular Now

New App may Help Caregivers of People Ge…

A new study by investigators from Mass General Brigham showed that a new app they created can help improve the quality of life for caregivers of patients undergoing bone marrow...

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...